METAPHORE
LIVE

Serial Number

97728343

Owner

Metaphore Biotechnologies, Inc.

Attorney

Christina M. Licursi

Filing Date

Dec 22, 2022

Add to watchlist:

No watchlists yet
View on USPTO

METAPHORE Trademark

Serial Number: 97728343

METAPHORE is a trademark filed by Metaphore Biotechnologies, Inc. on December 22, 2022. The trademark is classified under Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 42 (Computer & Scientific). The application is currently pending registration.

Owner Contact Info

Metaphore Biotechnologies, Inc. (4 trademarks)

55 Cambridge Parkway, Suite 800E
Cambridge, MA 02142

Entity Type: 03

Flagship Labs 72, Inc. (2 trademarks)

55 Cambridge Parkway, Suite 800E
Cambridge, MA 02142

Entity Type: 03

Trademark Details

Filing Date

December 22, 2022

Registration Date

Not Registered

Published for Opposition

January 16, 2024

Goods & Services

Downloadable software featuring artificial intelligence, computational methods, and machine learning models for data analysis in the fields of biomedical, and genomic research; downloadable software featuring artificial intelligence, computational methods, and machine learning models for the design and characterization of biologic therapeutic products and drug analysis in drug discovery and development; downloadable software for the capture, collection, conversion, analysis, communication, processing, receiving, recording, storage and transmission of data, images, information and artificial intelligence in the fields of healthcare, biomedical and genomic research

Pharmaceutical, therapeutic and biopharmaceutical preparations and agents for use in the treatment of autoimmune diseases, cancer, cardiovascular diseases and disorders, metabolic diseases and disorders, obesity, endocrine diseases and disorders, gastrointestinal diseases and disorders, hepatic diseases and disorders, nonalcoholic steatohepatitis, non-alcoholic fatty liver disease, ocular diseases and disorders, infectious diseases, psychiatric and psychological diseases and disorders, neurological diseases and disorders, rare diseases, and respiratory diseases and disorders

Scientific research, namely, research and analysis services in the fields of artificial intelligence and machine learning analytics and scientific and technological research relating to drug development; providing temporary use of online non-downloadable software featuring artificial intelligence, computational methods, and machine learning models for data analysis in the fields of biomedical, and genomic research; providing temporary use of online non-downloadable software featuring artificial intelligence, computational methods, and machine learning models for the design and characterization of biologic therapeutic products and drug analysis in drug discovery and development; providing temporary use of online non-downloadable software for the capture, collection, conversion, analysis, communication, processing, receiving, recording, storage and transmission of data, images, information and artificial intelligence in the fields of healthcare, biomedical and genomic research

Filing History

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sep 13, 2025 EXRA
SOU EXTENSION 3 GRANTED
Sep 12, 2025 EX3G
SOU EXTENSION 3 FILED
Sep 12, 2025 EXT3
SOU TEAS EXTENSION RECEIVED
Sep 12, 2025 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 13, 2025 EXRA
SOU EXTENSION 2 GRANTED
Mar 12, 2025 EX2G
SOU EXTENSION 2 FILED
Mar 12, 2025 EXT2
SOU TEAS EXTENSION RECEIVED
Mar 12, 2025 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sep 12, 2024 EXRA
SOU EXTENSION 1 GRANTED
Sep 12, 2024 EX1G
SOU EXTENSION 1 FILED
Sep 12, 2024 EXT1
SOU TEAS EXTENSION RECEIVED
Sep 12, 2024 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Mar 12, 2024 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jan 16, 2024 NPUB
PUBLISHED FOR OPPOSITION
Jan 16, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 27, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 13, 2023 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 9, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 8, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 8, 2023 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sep 27, 2023 GNRN
NON-FINAL ACTION E-MAILED
Sep 27, 2023 GNRT
NON-FINAL ACTION WRITTEN
Sep 27, 2023 CNRT
ASSIGNED TO EXAMINER
Sep 22, 2023 DOCK
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
May 24, 2023 ASGN
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 19, 2023 NWOS